Sign inGet started

HAMER JOHN

Insider CIK 1198174 · ABCL Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ABCL AbCellera Biologics Inc. S Sale2021-09-012021-09-02137,351$16.93 $2.33M128,862SEC↗
ABCL AbCellera Biologics Inc. S Sale2021-08-312021-09-02162,649$16.95 $2.76M266,213SEC↗
ABCL AbCellera Biologics Inc. J Other2021-06-182021-06-225,000,000— $024,105,761SEC↗
ABCL AbCellera Biologics Inc. J Other2021-06-182021-06-2273,892— $073,892SEC↗
ABCL AbCellera Biologics Inc. C Conversion deriv2020-12-152020-12-170— $00SEC↗
ABCL AbCellera Biologics Inc. C Conversion deriv2020-12-152020-12-170— $00SEC↗
ABCL AbCellera Biologics Inc. C Conversion deriv2020-12-152020-12-17802,371— $00SEC↗
ABCL AbCellera Biologics Inc. C Conversion2020-12-152020-12-1729,076,350— $029,076,350SEC↗
ABCL AbCellera Biologics Inc. C Conversion2020-12-152020-12-1729,411— $029,105,761SEC↗
ABCL AbCellera Biologics Inc. A Award deriv2020-12-112020-12-172,105,264$500000.00 $1052.63B0SEC↗